Post by Blueprint Medicines
72,632 followers
Listening to diverse perspectives is essential to improve understanding of systemic mastocytosis (SM). This year’s HERO Summit brought together voices from across the SM community to share aspirations for the future of care and drive actionable change — from reducing diagnostic delays, to increasing awareness, to strengthening collaboration among physicians and more. Hear more below from Dr. Ala Ebaid, an individual living with SM and our own Fatima Scipione. Sanofi
Video Content